[1]
S. Wang, L. S. Lau, and A. S. Lee, “CORPORATE ENVIRONMENTAL DISCLOSURE, CORPORATE GOVERNANCE, AND COST OF DEBT IN CHINA’S PHARMACEUTICAL INDUSTRY”, IJEMP, vol. 8, no. 31, Aug. 2025.